1. Home
  2. Media
  3. News
  4. Bioiberica to present two innovative branded ingredients for joint health and mobility at Wellfood Ingredients 2019

Bioiberica to present two innovative branded ingredients for joint health and mobility at Wellfood Ingredients 2019

3 Apr 2019
Healthcare
  • Mobilee® is a patented ingredient to maintain joint health and muscle function
  • b-2Cool® is a natural ingredient that provides native type II collagen to maintain joint health

Bioiberica Healthcare will participate, together with their Brazilian associate Ayalla (booth 25), at Wellfood Ingredients, which will be held at Sao Paulo (Brazil) on 3- 5 April 2019.

The company, with over 40 years’ experience in the research and development of nutritional ingredients and food supplements to improve joint health, will present two innovative branded ingredients: Mobilee® and b-2Cool®.

Mobilee® is a patented ingredient scientifically shown to maintain joint health and muscle function, with a high concentration of hyaluronic acid and other components including collagen and polysaccharides, which act in synergy to improve its effects. In ten pre-clinical and clinical studies, as well as a meta-analysis, Mobilee® demonstrated its efficacy. The main results show that Mobilee stimulates the endogenous synthesis of hyaluronic acid in vitro and helps to maintain joint health and to increase muscular strength (+17%).

b-2Cool® s a natural ingredient supplying native (undenatured) II collagen. Thanks to its native form, orally taken, it works through an immune-mediated mechanism of action called oral tolerance that modulates the immune response against endogenous type II collagen, helping to decrease its degradation.

Bioiberica has developed these two ingredients to respond to the steadily growing market of joint health products. “People want to enjoy an active, healthy lifestyle and are seeking new products to keep their joints healthy and Bioiberica has developed Mobilee® and b-2Cool® in order to respond to this market needs. Both branded ingredients have demonstrated efficacy at low dosages, making them a very convenient option to be formulated in any type of finished products”, declares Mr. Josep Maria Sánchez, Area Manager of Bioiberica Healthcare.

Mr. Sanchez will give a talk entitled “How to tackle joint health and mobility with an innovative and scientifically proven ingredient” (Speaker’s Corner, 4 April 2019, 16:20).

Bioiberica is a global Life Science company committed to improving people, animal, and plant health and well-being. It is the leading Heparin API manufacturer and a world reference in the research, production and sale of other animal-derived APIs, ingredients and compounds, such us chondroitin sulfate, glucosamine, hyaluronic acid, native type II collagen or thyroid.